The funding supports research across a variety of eye diseases and conditions, said Henry J. Kaplan, MD, department chair, Evans Professor of Ophthalmology and director of UofL’s Kentucky Lions Eye Center.
Among research conducted at UofL that RPB helps fund are studies examining the pharmacologic treatment of age-related macular degeneration, gene therapy in retinal degeneration, stem cell therapy in retinal degeneration, genetic mutations in hereditary night blindness, retinopathy of prematurity, autoimmune uveitis and more.
“We are grateful for the support from Research to Prevent Blindness,” Kaplan said. “With this help, we can continue to carry out groundbreaking research on the development, structure and function of the visual system and discover and develop new treatments for ocular disease.”
RPB is the world’s leading voluntary organization supporting eye research. Since it was founded in 1960, RPB has channeled hundreds of millions of dollars to medical institutions throughout the United States for research into all blinding eye diseases. For information on RPB, RPB-funded research, eye disorders and the RPB Grants Program, go to www.rpbusa.org.